The dimensions of the CRC problem

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 4, 2010, Pages 381-396

  Karsa, L V ^a   Lignini, T A ^a   Patnick, J ^b,c   Lambert, R ^a   Sauvaget, C ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cancer control; Colorectal cancer; Incidence; Mortality; Primary prevention; Screening; Trends

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; COLORECTAL CANCER; FEMALE; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LIFE EXPECTANCY; MALE;

COLORECTAL NEOPLASMS; COST OF ILLNESS; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH RESOURCES; HEALTH TRANSITION; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH;

EID: 77956574224     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.06.004     Document Type: Article

References (64)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase no. 10 [Internet] 2010 International Agency for Research on Cancer Lyon, France
2. Cancer incidence in five continents M.P. Curado, B. Edwards, H.R. Shin, H. Storm, J. Ferlay, M. Heanue, 2007 IARC Scientific Publications Lyon
3. Lv Karsa, A. Anttila, G. Ronco, A. Ponti, N. Malila, and M. Arbyn Cancer screening in the European Union-Report on the implementation of the Council recommendation on cancer screening First Report 2008 European Commission Luxembourg
4. R.R. Huxley, A. Ansary-Moghaddam, P. Clifton, S. Czernichow, C.L. Parr, and M. Woodward The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence Int J Cancer 125 1 2009 171 180
5. World Cancer Report Cancer site by site-colorectal cancer P. Boyle, B. Levin, World cancer report 2008 2008 International Agency for Research on Cancer Lyon 374 379
6. American Cancer Society Cancer prevention and early detection facts & figures 2008 2008 American Cancer Society Atlanta
7. C.G. Moertel, T.R. Fleming, J.S. Macdonald, D.G. Haller, J.A. Laurie, and P.J. Goodman Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 6 1990 352 358
8. S.F. Altekruse, C.L. Kosary, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, SEER cancer statistics review, 1975-2007 2010 National Cancer Institute Bethesda, MD
9. R. Capocaccia, A. Gavin, T. Hakulinen, J.M. Lutz, M. Sant, Survival of cancer patients in Europe, 1995-2002: the EUROCARE 4 study Eur J Cancer 45 6 2009 901 1094
10. R. Kato, T. Sobue, K. Katanoda, Y. Saito, H. Tsukuma, N. Saruki, Cancer statistics in Japan 2008 Tokyo, Japan
11. R. Sankaranarayanan, R. Swaminathan, H. Brenner, K. Chen, K.S. Chia, and J.G. Chen Cancer survival in Africa, Asia, and Central America: a population-based study Lancet Oncol 11 2 2010 165 173
12. A. Verdecchia, M. Santaquilani, and M. Sant Survival for cancer patients in Europe Ann Ist Super Sanita 45 3 2009 315 324
13. Y. Hirabayashi, and S. Tanaka Comparison of time trends in colorectal cancer incidence (1973-97) in East Asia, Europe and USA, from cancer incidence in five continents vol. IV-VIII Jpn J Clin Oncol 37 4 2007 325 327 (Pubitemid 47090688)
14. R.J. Troisi, A.N. Freedman, and S.S. Devesa Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994 Cancer 85 8 1999 1670 1676
15. World Cancer Research Fund The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007 AICR Washington DC
16. U.S. Preventive Services Task Force Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 149 9 2008 627 637
17. U.S. Preventive Services Task Force Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 146 5 2007 361 364
18. M. Jenab, H.B. Bueno-de-Mesquita, P. Ferrari, F.J. van Duijnhoven, T. Norat, and T. Pischon Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study BMJ 340 2010 b5500
19. European Code Against Cancer The European Code Against Cancer (third version) J Natl Cancer Inst 95 16 2003 1187
20. V.S. Benson, J. Patnick, A.K. Davies, M.R. Nadel, R.A. Smith, and W.S. Atkin Colorectal cancer screening: a comparison of 35 initiatives in 17 countries Int J Cancer 122 6 2008 1357 1367
21. W.S. Atkin, R. Edwards, I. Kralj-Hans, K. Wooldrage, A.R. Hart, and J.M. Northover Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet 375 9726 2010 1624 1633
22. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, S.S. Amar, and T.W. Balfour Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 9040 1996 1472 1477
23. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 9040 1996 1467 1471
24. J.S. Mandel, J.H. Bond, T.R. Church, D.C. Snover, G.M. Bradley, and L.M. Schuman Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 19 1993 1365 1371
25. Lansdorp-Vogelaar I, Karsa Lv. Introduction, chapter 1. In: Segnan N, Patnick J, Karsa Lv, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis, in preparation.
26. S.J. Winawer, A.G. Zauber, M.N. Ho, M.J. O'Brien, L.S. Gottlieb, and S.S. Sternberg Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 27 1993 1977 1981
27. G. Hoff, T. Grotmol, E. Skovlund, and M. Bretthauer Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial BMJ 338 2009 b1846
28. N. Segnan, C. Senore, B. Andreoni, H. Aste, L. Bonelli, and C. Crosta Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"-SCORE J Natl Cancer Inst 94 23 2002 1763 1772
29. J.L. Weissfeld, R.E. Schoen, P.F. Pinsky, R.S. Bresalier, T. Church, and S. Yurgalevitch Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial J Natl Cancer Inst 97 13 2005 989 997
30. NordICC The Northern-European initiative on colorectal cancer http://clinicaltrials.gov/ct2/show/NCT00883792 [Posted April 17 2009. Last updated 27 May 2010. Accessed 19 June 2010]
31. N. Perry, M. Broeders, C. de Wolf, S. Tornberg, Holland R. L.v. Karsa, European guidelines for quality assurance in breast cancer screening and diagnosis 4th ed 2006 European Commission. Office for Official Publications of the European Communities Luxembourg
32. Lv Karsa Mammographie Screening-umfassendes, populationsbezogenes Qualitätsmanagement ist hier gefragt! Mammography screening-comprehensive, population-based quality assurance is required! Z Allgemeinmed 71 1995 1863 1867
33. Council of the European Union Council recommendation of 2 December 2003 on cancer screening (2003/878/EC) Off J Eur Union L 327 2003 34 38
34. Austoker J, Giordano L, Hewitson P, Villain P. Communication, chapter 10. In: Segnan N, Patnick J, von Karsa L, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis, in preparation.
35. M. Arbyn, A. Anttila, J. Jordan, U. Schenck, G. Ronco, N. Segnan, European guidelines for quality assurance in cervical cancer screening 2nd ed. 2008 European Commission, Office for Official Publications of the European Communities Luxembourg
36. M. Arbyn, A. Anttila, J. Jordan, G. Ronco, U. Schenck, and N. Segnan European guidelines for quality assurance in cervical cancer screening. Second edition-summary document Ann Oncol 21 3 2010 448 458F
37. N. Perry, M. Broeders, C. de Wolf, S. Tornberg, R. Holland, and Lv Karsa European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition-summary document Ann Oncol 19 4 2008 614 622
38. Valori R, Rey J-F, Atkin W, Bretthauer M, Senore C, Hoff G, et al. Guidelines for quality assurance of endoscopy in colorectal cancer screening (and diagnosis). In: Segnan N, Patnick J, Karsa Lv, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis, in preparation.
39. B. Levin, D.A. Lieberman, B. McFarland, K.S. Andrews, D. Brooks, and J. Bond Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 5 2008 1570 1595 (Pubitemid 351615355)
40. D. Lieberman, M. Nadel, R.A. Smith, W. Atkin, S.B. Duggirala, and R. Fletcher Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable Gastrointest Endosc 65 6 2007 757 766
41. D.K. Rex, J.H. Bond, S. Winawer, T.R. Levin, R.W. Burt, and D.A. Johnson Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer Am J Gastroenterol 97 6 2002 1296 1308
42. U.S.Preventive Services Task Force Screening for colorectal cancer: recommendation and rationale Ann Intern Med 137 2 2002 129 131
43. S.J. Winawer, A.G. Zauber, R.H. Fletcher, J.S. Stillman, M.J. O'Brien, and B. Levin Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society Gastroenterology 130 6 2006 1872 1885 (Pubitemid 43668826)
44. Segnan N, Patnick J, Karsa Lv, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis, in preparation.
45. J.M. Walsh, and J.P. Terdiman Colorectal cancer screening: scientific review JAMA 289 10 2003 1288 1296
46. D.A. Lieberman, D.G. Weiss, J.H. Bond, D.J. Ahnen, H. Garewal, and G. Chejfec Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380 N Engl J Med 343 3 2000 162 168
47. N.N. Baxter, M.A. Goldwasser, L.F. Paszat, R. Saskin, D.R. Urbach, and L. Rabeneck Association of colonoscopy and death from colorectal cancer Ann Intern Med 150 1 2009 1 8
48. H. Brenner, J. Chang-Claude, C.M. Seiler, T. Sturmer, and M. Hoffmeister Does a negative screening colonoscopy ever need to be repeated? Gut 55 8 2006 1145 1150
49. H. Singh, D. Turner, L. Xue, L.E. Targownik, and C.N. Bernstein Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies JAMA 295 20 2006 2366 2373
50. K. Konishi, T. Fujii, N. Boku, S. Kato, I. Koba, and A. Ohtsu Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut 45 6 1999 818 821
51. S. Kudo, R. Lambert, J.I. Allen, H. Fujii, T. Fujii, and H. Kashida Nonpolypoid neoplastic lesions of the colorectal mucosa Gastrointest Endosc 68 4 Suppl. 2008 S3 S47
52. R. Lambert, S.E. Kudo, M. Vieth, J.I. Allen, H. Fujii, and T. Fujii Pragmatic classification of superficial neoplastic colorectal lesions Gastrointest Endosc 70 6 2009 1182 1199
53. M. Okamoto, T. Kawabe, Y. Yamaji, J. Kato, T. Ikenoue, and G. Togo Flat-type early colorectal cancer preferentially develops in right-sided colon in older patients Dis Colon Rectum 48 1 2005 101 107
54. R.M. Soetikno, T. Kaltenbach, R.V. Rouse, W. Park, A. Maheshwari, and T. Sato Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults JAMA 299 9 2008 1027 1035
55. The Paris classification The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002 Gastrointest Endosc 58 6 Suppl. 2003 S3 S43
56. N.N. Baxter, and L. Rabeneck Is the effectiveness of colonoscopy "good enough" for population-based screening? J Natl Cancer Inst 102 2 2010 70 71
57. Atkin W, Valori R, Kuipers EJ, Hoff G, Senore C, Segnan N, et al. Colonoscopic surveillance after adenoma removal. In: Segnan N, Patnick J, Karsa Lv, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis, in preparation.
58. A.G. Zauber, I. Lansdorp-Vogelaar, A.B. Knudsen, J. Wilschut, M. van Ballegooijen, and K.M. Kuntz Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force Ann Intern Med 149 9 2008 659 669
59. M. Hakama, E. Pukkala, B. Soderman, and N. Day Implementation of screening as a public health policy: issues in design and evaluation J Med Screen 6 4 1999 209 216
60. N. Malila, T. Oivanen, O. Malminiemi, and M. Hakama Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design BMJ 337 2008 a2261
61. E. Riboli, and T. Norat Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk Am J Clin Nutr 78 3 Suppl. 2003 559S 569S
62. International Cancer Screening Network Inventory of colorectal cancer screening activities in ICSN countries, May 2008 2008 http://appliedresearch. cancer.gov/icsn/colorectal/screening.html [accessed 20.06.10]
63. WHO Cancer control: knowledge into action. WHO guide for effective programmes. Planning 2006 World Health Organization Geneva, Switzerland
64. C.P. Wild Environmental exposure measurement in cancer epidemiology Mutagenesis 24 2 2009 117 125